Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning.

Journal: Briefings in bioinformatics
Published Date:

Abstract

Although some pyroptosis-related (PR) prognostic models for cancers have been reported, pyroptosis-based features have not been fully discovered at the single-cell level in hepatocellular carcinoma (HCC). In this study, by deeply integrating single-cell and bulk transcriptome data, we systematically investigated significance of the shared pyroptotic signature at both single-cell and bulk levels in HCC prognosis. Based on the pyroptotic signature, a robust PR risk system was constructed to quantify the prognostic risk of individual patient. To further verify capacity of the pyroptotic signature on predicting patients' prognosis, an attention mechanism-based deep neural network classification model was constructed. The mechanisms of prognostic difference in the patients with distinct PR risk were dissected on tumor stemness, cancer pathways, transcriptional regulation, immune infiltration and cell communications. A nomogram model combining PR risk with clinicopathologic data was constructed to evaluate the prognosis of individual patients in clinic. The PR risk could also evaluate therapeutic response to neoadjuvant therapies in HCC patients. In conclusion, the constructed PR risk system enables a comprehensive assessment of tumor microenvironment characteristics, accurate prognosis prediction and rational therapeutic options in HCC.

Authors

  • Yang Liu
    Department of Computer Science, Hong Kong Baptist University, Hong Kong, China.
  • Hanlin Li
    Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Tianyu Zeng
    School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
  • Yang Wang
    Department of General Surgery The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology Kunming China.
  • Hongqi Zhang
    China International Neuroscience Institute (China-INI), Beijing, China xwzhanghq@163.com qinlan@unionstrongtech.com.
  • Ying Wan
    Department of Mathematics, Southeast University, Nanjing 210096, China.
  • Zheng Shi
    Clinical Genetics Laboratory, Clinical Medical College & Affiliated Hospital, Chengdu University, Chengdu, China.
  • Renzhi Cao
    Department of Computer Science, Pacific Lutheran University, Tacoma, WA, 98447, USA.
  • Hua Tang
    Chongqing Institute for Food and Drug Control, Chongqing 401121, China.